Publicacions en què col·labora amb Joaquín Barba Cosials (20)

2017

  1. Epicardial Adipose Tissue in the General Middle-aged Population and Its Association With Metabolic Syndrome

    Revista Espanola de Cardiologia, Vol. 70, Núm. 4, pp. 254-260

2015

  1. Association of low GLP-1 with oxidative stress is related to cardiac disease and outcome in patients with type 2 diabetes mellitus: A pilot study

    Free Radical Biology and Medicine, Vol. 81, pp. 1-12

2013

  1. Association of cardiotrophin-1 with left ventricular systolic properties in asymptomatic hypertensive patients

    Journal of Hypertension, Vol. 31, Núm. 3, pp. 587-594

  2. The activity of circulating dipeptidyl peptidase-4 is associated with subclinical left ventricular dysfunction in patients with type 2 diabetes mellitus

    Cardiovascular Diabetology, Vol. 12, Núm. 1

2012

  1. The influence of obesity on the assessment of carotid intima-media thickness

    Journal of Clinical Ultrasound, Vol. 40, Núm. 8, pp. 479-485

2011

  1. Association of the peroxisome proliferator-activated receptor α gene L162V polymorphism with stage C heart failure

    Journal of Hypertension, Vol. 29, Núm. 5, pp. 876-883

2010

  1. Association between metabolic syndrome or its components and asymptomatic cardiovascular disease in the RIVANA-study

    Atherosclerosis, Vol. 211, Núm. 2, pp. 612-617

2009

  1. Association of plasma cardiotrophin-1 with stage C heart failure in hypertensive patients: Potential diagnostic implications

    Journal of Hypertension, Vol. 27, Núm. 2, pp. 418-424

2008

  1. Mechanical dyssynchrony: Another mechanism of left ventricular dysfunction in hypertension?

    Journal of Hypertension

  2. Response to association of increased plasma cardiotrophin-1 with left ventricular mass indexes in normotensive morbid obesity [4]

    Hypertension

2007

  1. Association of increased plasma cardiotrophin-1 with inappropriate left ventricular mass in essential hypertension

    Hypertension, Vol. 50, Núm. 5, pp. 977-983

  2. Estudio de riesgo vascular en Navarra: objetivos y diseño. Prevalencia del síndrome metabólico y de los factores mayores de riesgo vascular

    Anales del sistema sanitario de Navarra, Vol. 30, Núm. 1, pp. 113-124

2005

  1. Characteristics of hypertensive cardiomyopathy in a population of hypertensive patients never treated

    Medicina Clinica, Vol. 125, Núm. 9

  2. Is plasma cardiotrophin-1 a marker of hypertensive heart disease?

    Journal of Hypertension, Vol. 23, Núm. 3, pp. 625-632

  3. La presión arterial domiciliaria se asocia con la hipertrofia concéntrica del ventrículo izquierdo

    Hipertensión y riesgo vascular, Vol. 22, Núm. 7, pp. 284-290

  4. Usefulness of plasma cardiotrophin-1 in assessment of left ventricular hypertrophy regression in hypertensive patients

    Journal of Hypertension, Vol. 23, Núm. 12, pp. 2297-2304

2003

  1. Independent association of fibrinogen with carotid intima-media thickness in asymptomatic subjects

    Cerebrovascular Diseases, Vol. 16, Núm. 4, pp. 356-362

2002

  1. Ultrasonic backscatter and diastolic function in hypertensive patients

    Hypertension, Vol. 40, Núm. 3, pp. 239-243

  2. Ultrasonic backscatter and serum marker of cardiac fibrosis in hypertensives

    Hypertension, Vol. 39, Núm. 4, pp. 923-928

1991

  1. TRATAMIENTO DE LA HIPERTENSION ARTERIAL ESENCIAL

    Ciencia Medica, Vol. 8, Núm. 6, pp. 214-227